Hyperfine, Inc. (HYPR) – What Are Analysts Saying About This Stock?

Shares of Hyperfine, Inc. (NASDAQ:HYPR) have been assigned an average rating of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $2.02.

HYPR has been the subject of a number of analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a research report on Thursday, October 15th. Lucid Cap Mkts initiated coverage on shares of Hyperfine in a research report on Tuesday, October 27th. They set a “strong-buy” rating on the stock. Wall Street Zen cut shares of Hyperfine from a “hold” rating to a “sell” rating in a research note on Sunday. B. Riley Financial reiterated a “buy” rating and issued a $1.60 price target (down from $2.00) on shares of Hyperfine in a report on Monday, August 10th. Finally, Loop Capital set a $2.00 price target on Hyperfine in a research note on Tuesday, October 27th.

Hyperfine Trading Up 5.0%

Shares of HYPR stock opened at $0.72 on Friday. The company has a market capitalization of $76.30 million, a price-to-earnings ratio of -1.89 and a beta of 1.49. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. The firm has a 50-day moving average price of $0.80 and a 200 day moving average price of $1.11. Hyperfine has a twelve month low of $0.67 and a twelve month high of $1.94.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). The company had revenue of $3.90 million for the quarter, compared to analysts’ expectations of $4.13 million. Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. Research analysts forecast that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Hyperfine

Institutional investors have recently added to or reduced their stakes in the business. Russell Investments Group Ltd. boosted its stake in Hyperfine by 7,695.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 487,994 shares of the company’s stock worth $394,000 after buying an additional 481,734 shares during the last quarter. PFS Partners LLC grew its holdings in Hyperfine by 150.0% in the 3rd quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock valued at $40,000 after buying an additional 30,000 shares during the period. Bank of New York Mellon Corp acquired a new position in shares of Hyperfine during the 2nd quarter valued at about $419,000. Renaissance Technologies LLC increased its stake in shares of Hyperfine by 100.2% during the 1st quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after acquiring an additional 365,490 shares during the last quarter. Finally, Walleye Capital LLC increased its stake in shares of Hyperfine by 3.4% during the 1st quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock valued at $242,000 after acquiring an additional 7,330 shares during the last quarter. 15.03% of the stock is currently owned by institutional investors and hedge funds.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.